HEXO Corp. HEXO
$ 0.71
2.45%
Annual report 2022
added 12-23-2023
Country |
- |
IPO year |
- |
Industry |
Drug manufacturers |
Stock Exchange |
NYSE |
CEO |
Mr. Sebastien St-Louis |
Employees in the company |
- |
Shares |
- |
Market Cap[1] |
$ 38.1 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.